{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:36:10Z","timestamp":1794918970241,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801273"],"award-info":[{"award-number":["81801273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874357"],"award-info":[{"award-number":["81874357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["cstc2018jcyjAX0183"],"award-info":[{"award-number":["cstc2018jcyjAX0183"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Projects of second Affiliated Hospital, Army Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>Dopamine deficiency is mainly caused by apoptosis of dopaminergic nerve cells in the substantia nigra of the midbrain and the striatum and is an important pathologic basis of Parkinson\u2019s disease (PD). Recent research has shown that dynamin-related protein 1 (Drp1)-mediated aberrant mitochondrial fission plays a crucial role in dopaminergic nerve cell apoptosis. However, the upstream regulatory mechanism remains unclear. Our study showed that Drp1 knockdown inhibited aberrant mitochondrial fission and apoptosis. Importantly, we found that ROCK1 was activated in an MPP<jats:sup>+<\/jats:sup>-induced PD cell model and that ROCK1 knockdown and the specific ROCK1 activation inhibitor Y-27632 blocked Drp1-mediated aberrant mitochondrial fission and apoptosis of dopaminergic nerve cells by suppressing Drp1 dephosphorylation\/activation. Our in vivo study confirmed that Y-27632 significantly improved symptoms in a PD mouse model by inhibiting Drp1-mediated aberrant mitochondrial fission and apoptosis. Collectively, our findings suggest an important molecular mechanism of PD pathogenesis involving ROCK1-regulated dopaminergic nerve cell apoptosis via the activation of Drp1-induced aberrant mitochondrial fission.<\/jats:p>","DOI":"10.1038\/s12276-019-0318-z","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T08:05:59Z","timestamp":1570003559000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["ROCK1 induces dopaminergic nerve cell apoptosis via the activation of Drp1-mediated aberrant mitochondrial fission in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"51","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changpeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faning","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,2]]},"reference":[{"key":"318_CR1","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2147\/NDT.S85380","volume":"11","author":"YM Zou","year":"2015","unstructured":"Zou, Y. M., Liu, J., Tian, Z. Y., Lu, D. & Zhou, Y. Y. Systematic review of the prevalence and incidence of Parkinson\u2019s disease in the People\u2019s Republic of China. Neuropsychiatr. Dis. Treat. 11, 1467\u20131472 (2015).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"318_CR2","doi-asserted-by":"crossref","first-page":"Ii19","DOI":"10.1007\/s00415-002-1204-4","volume":"249","author":"R Katzenschlager","year":"2002","unstructured":"Katzenschlager, R. & Lees, A. J. Treatment of Parkinson\u2019s disease: levodopa as the first choice. J. Neurol. 249, Ii19\u2013Ii24 (2002).","journal-title":"J. Neurol."},{"issue":"3","key":"318_CR3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/ijms18030551","volume":"18","author":"Ram\u00f3n Cacabelos","year":"2017","unstructured":"Cacabelos, R. Parkinson\u2019s disease: from pathogenesis to pharmacogenomics. Int. J. Mol. Sci. 18, E551 (2017).","journal-title":"International Journal of Molecular Sciences"},{"key":"318_CR4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/mds.26966","volume":"32","author":"MP Giannoccaro","year":"2017","unstructured":"Giannoccaro, M. P., La Morgia, C., Rizzo, G., Carelli, V. & Mitochondrial, D. N. A. and primary mitochondrial dysfunction in Parkinson\u2019s disease. Mov. Disord. 32, 346\u2013363 (2017).","journal-title":"Mov. Disord."},{"key":"318_CR5","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6244","volume":"5","author":"PM Rappold","year":"2014","unstructured":"Rappold, P. M. et al. Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo. Nat. Commun. 5, 5244 (2014).","journal-title":"Nat. Commun."},{"key":"318_CR6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0079-6123(10)83006-7","volume":"183","author":"C Vives-Bauza","year":"2010","unstructured":"Vives-Bauza, C. et al. Control of mitochondrial integrity in Parkinson\u2019s disease. Prog. Brain Res. 183, 99\u2013113 (2010).","journal-title":"Prog. Brain Res."},{"key":"318_CR7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/ars.2012.4830","volume":"19","author":"N Ishihara","year":"2013","unstructured":"Ishihara, N., Otera, H., Oka, T. & Mihara, K. Regulation and physiologic functions of GTPases in mitochondrial fusion and fission in mammals. Antioxid. Redox Signal. 19, 389\u2013399 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"318_CR8","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201744860","volume":"19","author":"N Inoue","year":"2018","unstructured":"Inoue, N. et al. Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism. EMBO Rep. 19, e44860 (2018).","journal-title":"EMBO Rep."},{"key":"318_CR9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm.3983","volume":"22","author":"WZ Wang","year":"2016","unstructured":"Wang, W. Z. et al. Parkinson\u2019s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat. Med. 22, 54\u20135 (2016).","journal-title":"Nat. Med."},{"key":"318_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneurol.2014.228","volume":"11","author":"F Burte","year":"2015","unstructured":"Burte, F., Carelli, V., Chinnery, P. F. & Yu-Wai-Man, P. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 11, 11\u201324 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"318_CR11","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/hmg\/dds003","volume":"21","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum. Mol. Genet. 21, 1931\u20131944 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"318_CR12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1474-9726.2011.00721.x","volume":"10","author":"XL Wang","year":"2011","unstructured":"Wang, X. L. et al. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson\u2019s disease. Aging Cell 10, 807\u2013823 (2011).","journal-title":"Aging Cell"},{"key":"318_CR13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/0008-5472.CAN-08-2962","volume":"69","author":"JX Wang","year":"2009","unstructured":"Wang, J. X., Li, Q. & Li, P. F. Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1. Cancer Res. 69, 492\u2013500 (2009).","journal-title":"Cancer Res."},{"key":"318_CR14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.molcel.2008.02.005","volume":"29","author":"A Tanaka","year":"2008","unstructured":"Tanaka, A. & Youle, R. J. A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis. Mol. Cell 29, 409\u2013410 (2008).","journal-title":"Mol. Cell"},{"key":"318_CR15","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.cdd.4402107","volume":"14","author":"J Estaquier","year":"2007","unstructured":"Estaquier, J. & Arnoult, D. Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis. Cell Death Differ. 14, 1086\u20131094 (2007).","journal-title":"Cell Death Differ."},{"key":"318_CR16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1534-5807(01)00055-7","volume":"1","author":"S Frank","year":"2001","unstructured":"Frank, S. et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 1, 515\u2013525 (2001).","journal-title":"Dev. Cell"},{"key":"318_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00005-015-0382-6","volume":"64","author":"L Wei","year":"2016","unstructured":"Wei, L., Surma, M., Shi, S., Lambert-Cheatham, N. & Shi, J. Novel insights into the roles of Rho kinase in cancer. Arch. Immunol. Ther. Exp. (Warsz.) 64, 259\u2013278 (2016).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"318_CR18","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1182\/blood-2009-08-237222","volume":"115","author":"S Vemula","year":"2010","unstructured":"Vemula, S., Shi, J. J., Hanneman, P., Wei, L. & Kapur, R. ROCK1 functions as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Blood 115, 1785\u20131796 (2010).","journal-title":"Blood"},{"key":"318_CR19","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.18632\/oncotarget.2795","volume":"6","author":"GB Li","year":"2015","unstructured":"Li, G. B. et al. Mitochondrial translocation and interaction of cofilin and Drp1 are required for erucin-induced mitochondrial fission and apoptosis. Oncotarget 6, 1834\u20131849 (2015).","journal-title":"Oncotarget"},{"key":"318_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ejn.13132","volume":"43","author":"Q He","year":"2016","unstructured":"He, Q. et al. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson\u2019s model. Eur. J. Neurosci. 43, 41\u201352 (2016).","journal-title":"Eur. J. Neurosci."},{"key":"318_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.05.021","volume":"85","author":"A Borrajo","year":"2014","unstructured":"Borrajo, A., Rodriguez-Perez, A. I., Villar-Cheda, B., Guerra, M. J. & Labandeira-Garcia, J. L. Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death. Neuropharmacology 85, 1\u20138 (2014).","journal-title":"Neuropharmacology"},{"key":"318_CR22","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s12035-016-9747-z","volume":"54","author":"DB Santos","year":"2017","unstructured":"Santos, D. B. et al. Succinobucol, a non-statin hypocholesterolemic drug, prevents premotor symptoms and nigrostriatal neurodegeneration in an experimental model of Parkinson\u2019s disease. Mol. Neurobiol. 54, 1513\u20131530 (2017).","journal-title":"Mol. Neurobiol."},{"key":"318_CR23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuropharm.2017.08.014","volume":"126","author":"B Guo","year":"2017","unstructured":"Guo, B. et al. Substantial protection against MPTP-associated Parkinson\u2019s neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B. Neuropharmacology 126, 12\u201324 (2017).","journal-title":"Neuropharmacology"},{"key":"318_CR24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nbd.2012.04.010","volume":"47","author":"B Villar-Cheda","year":"2012","unstructured":"Villar-Cheda, B. et al. Involvement of microglial RhoA\/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors. Neurobiol. Dis. 47, 268\u2013279 (2012).","journal-title":"Neurobiol. Dis."},{"key":"318_CR25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mito.2014.05.010","volume":"17","author":"J Singleterry","year":"2014","unstructured":"Singleterry, J., Sreedhar, A. & Zhao, Y. F. Components of cancer metabolism and therapeutic interventions. Mitochondrion 17, 50\u201355 (2014).","journal-title":"Mitochondrion"},{"key":"318_CR26","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1038\/sj.onc.1209607","volume":"25","author":"M Brandon","year":"2006","unstructured":"Brandon, M., Baldi, P. & Wallace, D. C. Mitochondrial mutations in cancer. Oncogene 25, 4647\u20134662 (2006).","journal-title":"Oncogene"},{"key":"318_CR27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0098-2997(99)00008-4","volume":"20","author":"VP Skulachev","year":"1999","unstructured":"Skulachev, V. P. Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells and organisms. Mol. Asp. Med. 20, 139\u2013184 (1999).","journal-title":"Mol. Asp. Med."},{"key":"318_CR28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.14712\/23362936.2014.41","volume":"115","author":"J Pokorny","year":"2014","unstructured":"Pokorny, J. et al. Targeting mitochondria for cancer treatment - two types of mitochondrial dysfunction. Prague Med. Rep. 115, 104\u2013119 (2014).","journal-title":"Prague Med. Rep."},{"key":"318_CR29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1158\/1940-6207.CAPR-14-0405","volume":"8","author":"S Safe","year":"2015","unstructured":"Safe, S. Targeting apoptosis pathways in cancer\u2013letter. Cancer Prev. Res. (Phila.) 8, 338 (2015).","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"318_CR30","volume":"6","author":"C Murugan","year":"2016","unstructured":"Murugan, C. et al. Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy. Sci. Rep. 6, 34053 (2016).","journal-title":"Sci. Rep."},{"key":"318_CR31","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","volume":"26","author":"JM Adams","year":"2007","unstructured":"Adams, J. M. & Cory, S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324\u20131337 (2007).","journal-title":"Oncogene"},{"key":"318_CR32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.mito.2010.08.005","volume":"10","author":"C Sheridan","year":"2010","unstructured":"Sheridan, C. & Martin, S. J. Mitochondrial fission\/fusion dynamics and apoptosis. Mitochondrion 10, 640\u2013648 (2010).","journal-title":"Mitochondrion"},{"key":"318_CR33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tcb.2005.02.005","volume":"15","author":"JL Perfettini","year":"2005","unstructured":"Perfettini, J. L., Roumier, T. & Kroemer, G. Mitochondrial fusion and fission in the control of apoptosis. Trends Cell Biol. 15, 179\u2013183 (2005).","journal-title":"Trends Cell Biol."},{"key":"318_CR34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jb\/mvr002","volume":"149","author":"H Otera","year":"2011","unstructured":"Otera, H. & Mihara, K. Molecular mechanisms and physiologic functions of mitochondrial dynamics. J. Biochem. 149, 241\u2013251 (2011).","journal-title":"J. Biochem."},{"key":"318_CR35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrn2417","volume":"9","author":"AB Knott","year":"2008","unstructured":"Knott, A. B., Perkins, G., Schwarzenbacher, R. & Bossy-Wetzel, E. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9, 505\u2013518 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"318_CR36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biochi.2006.08.003","volume":"89","author":"JH Kang","year":"2007","unstructured":"Kang, J. H. et al. Phosphorylation of Rho-associated kinase (Rho-kinase\/ROCK\/ROK) substrates by protein kinases A and C. Biochimie 89, 39\u201347 (2007).","journal-title":"Biochimie"},{"key":"318_CR37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cmet.2012.01.009","volume":"15","author":"WJ Wang","year":"2012","unstructured":"Wang, W. J. et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab. 15, 186\u2013200 (2012).","journal-title":"Cell Metab."},{"key":"318_CR38","doi-asserted-by":"crossref","first-page":"a009316","DOI":"10.1101\/cshperspect.a009316","volume":"1","author":"K Tieu","year":"2011","unstructured":"Tieu, K. A guide to neurotoxic animal models of Parkinson\u2019s disease. Cold Spring Harb. Perspect. Med. 1, a009316 (2011).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"318_CR39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"GC Davis","year":"1979","unstructured":"Davis, G. C. et al. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1, 249\u2013254 (1979).","journal-title":"Psychiatry Res."},{"key":"318_CR40","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston, J. W., Ballard, P., Tetrud, J. W. & Irwin, I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979\u2013980 (1983).","journal-title":"Science"},{"key":"318_CR41","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1073\/pnas.0705363105","volume":"105","author":"ME Haque","year":"2008","unstructured":"Haque, M. E. et al. Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc. Natl Acad. Sci. USA 105, 1716\u20131721 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"318_CR42","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ceb.2003.10.015","volume":"15","author":"E Bossy-Wetzel","year":"2003","unstructured":"Bossy-Wetzel, E., Barsoum, M. J., Godzik, A., Schwarzenbacher, R. & Lipton, S. A. Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr. Opin. Cell Biol. 15, 706\u2013716 (2003).","journal-title":"Curr. Opin. Cell Biol."},{"key":"318_CR43","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.cdd.4401260","volume":"10","author":"M Karbowski","year":"2003","unstructured":"Karbowski, M. & Youle, R. J. Dynamics of mitochondrial morphology in healthy cells and during apoptosis. Cell Death Differ. 10, 870\u2013880 (2003).","journal-title":"Cell Death Differ."},{"key":"318_CR44","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1242\/jcs.02415","volume":"118","author":"D Tondera","year":"2005","unstructured":"Tondera, D. et al. The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells. J. Cell Sci. 118, 3049\u20133059 (2005).","journal-title":"J. Cell Sci."},{"key":"318_CR45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","volume":"17","author":"W Song","year":"2011","unstructured":"Song, W. et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat. Med. 17, 377\u2013382 (2011).","journal-title":"Nat. Med."},{"key":"318_CR46","doi-asserted-by":"crossref","first-page":"73.e15","DOI":"10.1016\/j.cell.2018.12.013","volume":"176","author":"V Rangaraju","year":"2019","unstructured":"Rangaraju, V., Lauterbach, M. & Schuman, E. M. Spatially stable mitochondrial compartments fuel local translation during plasticity. Cell 176, 73.e15\u201384.e15 (2019).","journal-title":"Cell"},{"key":"318_CR47","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1091\/mbc.e12-10-0721","volume":"24","author":"OC Loson","year":"2013","unstructured":"Loson, O. C., Song, Z., Chen, H. & Chan, D. C. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol. Biol. Cell 24, 659\u2013667 (2013).","journal-title":"Mol. Biol. Cell"},{"key":"318_CR48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41586-018-0211-2","volume":"558","author":"R Kalia","year":"2018","unstructured":"Kalia, R. et al. Structural basis of mitochondrial receptor binding and constriction by DRP1. Nature 558, 401\u2013405 (2018).","journal-title":"Nature"},{"key":"318_CR49","first-page":"34","volume":"1201","author":"CR Chang","year":"2010","unstructured":"Chang, C. R. & Blackstone, C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Mitochondrial Res. Transl. Med. 1201, 34\u201339 (2010).","journal-title":"Mitochondrial Res. Transl. Med."},{"key":"318_CR50","doi-asserted-by":"crossref","first-page":"15803","DOI":"10.1073\/pnas.0808249105","volume":"105","author":"GM Cereghetti","year":"2008","unstructured":"Cereghetti, G. M. et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl Acad. Sci. USA 105, 15803\u201315808 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"318_CR51","doi-asserted-by":"crossref","first-page":"10359","DOI":"10.18632\/oncotarget.14413","volume":"8","author":"GB Li","year":"2017","unstructured":"Li, G. B. et al. Polyphyllin I induces mitophagic and apoptotic cell death in human breast cancer cells by increasing mitochondrial PINK1 levels. Oncotarget 8, 10359\u201310374 (2017).","journal-title":"Oncotarget"},{"key":"318_CR52","doi-asserted-by":"crossref","DOI":"10.4161\/sgtp.29846","volume":"5","author":"L Julian","year":"2014","unstructured":"Julian, L. & Olson, M. F. Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions. Small GTPases 5, e29846 (2014).","journal-title":"Small GTPases"},{"key":"318_CR53","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1038\/onc.2010.3","volume":"29","author":"PA Lochhead","year":"2010","unstructured":"Lochhead, P. A., Wickman, G., Mezna, M. & Olson, M. F. Activating ROCK1 somatic mutations in human cancer. Oncogene 29, 2591\u20132598 (2010).","journal-title":"Oncogene"},{"key":"318_CR54","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.cellsig.2009.12.001","volume":"22","author":"NP Tsai","year":"2010","unstructured":"Tsai, N. P. & Wei, L. N. RhoA\/ROCK1 signaling regulates stress granule formation and apoptosis. Cell Signal. 22, 668\u2013675 (2010).","journal-title":"Cell Signal."},{"key":"318_CR55","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.embor.7401062","volume":"8","author":"JT Cribbs","year":"2007","unstructured":"Cribbs, J. T. & Strack, S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 8, 939\u2013944 (2007).","journal-title":"EMBO Rep."},{"key":"318_CR56","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.bbamcr.2014.05.012","volume":"1843","author":"L Buhlman","year":"2014","unstructured":"Buhlman, L. et al. Functional interplay between Parkin and Drp1 in mitochondrial fission and clearance. Biochim. Biophys. Acta 1843, 2012\u20132026 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"318_CR57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fphys.2016.00433","volume":"7","author":"N Soudani","year":"2016","unstructured":"Soudani, N. et al. Calcineurin\/NFAT activation-dependence of leptin synthesis and vascular growth in response to mechanical stretch. Front. Physiol. 7, 433 (2016).","journal-title":"Front. Physiol."},{"key":"318_CR58","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cmet.2017.01.003","volume":"25","author":"A Santoro","year":"2017","unstructured":"Santoro, A. et al. DRP1 suppresses leptin and glucose sensing of POMC neurons. Cell Metab. 25, 647\u2013660 (2017).","journal-title":"Cell Metab."},{"key":"318_CR59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2016.06.008","volume":"434","author":"A Li","year":"2016","unstructured":"Li, A. et al. Metformin and resveratrol inhibit Drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice. Mol. Cell. Endocrinol. 434, 36\u201347 (2016).","journal-title":"Mol. Cell. Endocrinol."},{"key":"318_CR60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2017.02.019","volume":"306","author":"J Park","year":"2017","unstructured":"Park, J. et al. Anti-inflammatory effect of oleuropein on microglia through regulation of Drp1-dependent mitochondrial fission. J. Neuroimmunol. 306, 46\u201352 (2017).","journal-title":"J. Neuroimmunol."},{"key":"318_CR61","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.expneurol.2017.06.003","volume":"295","author":"K Zhou","year":"2017","unstructured":"Zhou, K. et al. RIP1-RIP3-DRP1 pathway regulates NLRP3 inflammasome activation following subarachnoid hemorrhage. Exp. Neurol. 295, 116\u2013124 (2017).","journal-title":"Exp. Neurol."},{"key":"318_CR62","volume":"12","author":"L Zhang","year":"2017","unstructured":"Zhang, L. et al. Drp1-dependent mitochondrial fission mediates osteogenic dysfunction in inflammation through elevated production of reactive oxygen species. PLoS ONE 12, e0175262 (2017).","journal-title":"PLoS ONE"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0318-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0318-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0318-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:00Z","timestamp":1684617060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0318-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1038\/s12276-019-0318-z","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"18 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}